Cancer of Brain clinical trials at UCSF

• Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

  Sorry, in progress, not accepting new patients

  The study is an open-label pilot study in newly diagnosed glioblastoma patients following surgery. Eligible patients will receive treatment with tumor treating fields therapy using the Optune device starting less than 2 weeks prior to start of chemoradiation. Patients will receive radiation and temozolomide at a routine treatment dose and schedule.

  San Francisco, California and other locations

Last updated: April 11, 2021